Garnier hired to restructure French firm

What's GlaxoSmithKline's ex-CEO Jean-Pierre Garnier up to these days? Well, in addition to director and advisory roles he holds at United Technologies, Renault, and the sovereign fund Dubai Capital, Garnier is expected to "return to his French roots" as chief executive of the health and beauty company Pierre Fabre.

As you know, Garnier retired from GSK in May, leaving new CEO Andrew Witty in charge. His mandate at Fabre, the Financial Times reports, will be the restructuring of the company, which is located in southwest France. Garnier has plenty of experience at overhauls: He engineered a big one, with thousands of layoffs, just before turning over GSK's reins to Witty.

- see the FT story


Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.